SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001493152-23-034861
Filing Date
2023-09-29
Accepted
2023-09-29 16:30:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 90771
  Complete submission text file 0001493152-23-034861.txt   92392
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Subject) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93313 | Film No.: 231296111
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 760-471-8536
Murphy Canyon Acquisition Sponsor, LLC (Filed by) CIK: 0001910050 (see all company filings)

IRS No.: 873307838 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A